Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 15452309.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7% of the participants developed headaches. The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.
Medical subject headings
- Acetaminophen
- Analgesics, Non-Narcotic
- Aspirin
- Dipyridamole
- Headache